These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24828120)

  • 1. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
    Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
    Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
    Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
    Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
    Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
    Bandiera T; Ponzano S; Piomelli D
    Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
    Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
    ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
    J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
    [No Abstract]   [Full Text] [Related]  

  • 7. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
    Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
    PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
    Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
    J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
    Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
    J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
    Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies.
    Nuzzi A; Fiasella A; Ortega JA; Pagliuca C; Ponzano S; Pizzirani D; Bertozzi SM; Ottonello G; Tarozzo G; Reggiani A; Bandiera T; Bertozzi F; Piomelli D
    Eur J Med Chem; 2016 Mar; 111():138-59. PubMed ID: 26866968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
    Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
    Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
    Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
    J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
    Fotio Y; Ciccocioppo R; Piomelli D
    Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
    Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
    Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
    Ribeiro A; Pontis S; Mengatto L; Armirotti A; Chiurchiù V; Capurro V; Fiasella A; Nuzzi A; Romeo E; Moreno-Sanz G; Maccarrone M; Reggiani A; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Aug; 10(8):1838-46. PubMed ID: 25874594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent
    Di Fruscia P; Carbone A; Bottegoni G; Berti F; Giacomina F; Ponzano S; Pagliuca C; Fiasella A; Pizzirani D; Ortega JA; Nuzzi A; Tarozzo G; Mengatto L; Giampà R; Penna I; Russo D; Romeo E; Summa M; Bertorelli R; Armirotti A; Bertozzi SM; Reggiani A; Bandiera T; Bertozzi F
    J Med Chem; 2021 Sep; 64(18):13327-13355. PubMed ID: 34469137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
    Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active
    Fotio Y; Sasso O; Ciccocioppo R; Piomelli D
    J Pharmacol Exp Ther; 2021 Aug; 378(2):70-76. PubMed ID: 33986036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.